Business
With the Moderna share price blasting up, have the forward-looking markets got it right?
The Moderna Inc (NASDAQ: MRNA) share price went like gangbusters yesterday, overnight Aussie time. The US biotech company’s share price leapt 10.8%. And its up another 3.8% in afterhours trading.
This comes as investors eagerly anticipate the outcome of the final analysis of Moderna’s promising COVID-19 vaccine trial.
Earlier this month, Moderna joined Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) in a globally exclusive club when the company announced its vaccine looked to be 95% effective in its extensive trial. One which encompassed 30,000 people.
Moderna’s share price is now up 62% so far in November, and 468% so far in 2020. At the current share price, Moderna has a market cap of $48 billion.
What does Moderna…
-
General16 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
General22 hours agoEnergy chiefs say net zero ‘irreversible’ even though bills unlikely to fall ‘for a decade’
-
Business12 hours agoWhat it means for shareholders
-
Business15 hours agoUp 48% in a month, can Domino’s Pizza shares keep the momentum going?